Expand ZYME Menu
ZYME MENU

Zymeworks (ZYME) closed at $25.84 on November 17, 2026, down 2.3% from the previous close, on volume of 528,715 shares (30-day average 1,332,325).

Key numbers
  • Last close: $25.84 (November 17, 2026)
  • 52-week range: $21.52 to $31.97
  • Market value: $1.8 billion
  • 30-day implied volatility (IV30): 52.5%
  • Option volume: 7 contracts (7 calls, 0 puts); 30-day average 1,225

Data as of November 17, 2026.

ZYME Stock Summary and Trading Ideas (Zymeworks | NASDAQ:ZYME)

Charts for Today's Stock Price and Implied Volatility in Zymeworks

17-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ZYME by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Zymeworks (ZYME) Frequently Asked Questions

What does Zymeworks do?

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

What symbol and exchange does Zymeworks shares trade?

Zymeworks trades on the NASDAQ stock market under the symbol ZYME.

What is Zymeworks stock price doing today?

As of November 17, 2026, ZYME stock price declined to $25.84 with 528,715 million shares trading.

What is Zymeworks's Beta?

ZYME has a beta of -0.14, meaning it tends to be less sensitive to market movements. ZYME has a correlation of 0.00 to the broad based SPY ETF.

How much is Zymeworks worth?

ZYME has a market cap of $1.81 billion. This is considered a Small Cap stock.

How much money does Zymeworks make?

Last quarter Zymeworks reported $256 million in Revenue and $2.28 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Zymeworks traded in the last 3 year period?

In the last 3 years, ZYME traded as high as $31.97 and as low as $7.97.

What are the top ETFs holding Zymeworks?

The top ETF exchange traded funds that ZYME belongs to (by Net Assets): VTI, IWM, IBB, IWO, DFAS.

Is Zymeworks (ZYME) a good investment?

ZYME has underperformed the market in the last year with a price return of +8.1% while the SPY ETF gained +11.2%. However, in the short term, ZYME had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.1% vs -5.0% return in SPY. But in the last 2 weeks, ZYME shares have been beat by the market, returning -14.2% compared to an SPY return of -2.9%.

What are the support and resistance levels for Zymeworks (ZYME)?

ZYME support price is $25.52 and resistance is $27.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZYME shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes